Literature DB >> 34711112

Gut non-bacterial microbiota contributing to alcohol-associated liver disease.

Wenkang Gao1, Yixin Zhu2, Jin Ye1, Huikuan Chu1.   

Abstract

Intestinal microbiota, dominated by bacteria, plays an important role in the occurrence and the development of alcohol-associated liver disease (ALD), which is one of the most common liver diseases around the world. With sufficient studies focusing on the gut bacterial community, chronic alcohol consumption is now known as a key factor that alters the composition of gut bacterial community, increases intestinal permeability, causes intestinal dysfunction, induces bacterial translocation, and exacerbates the process of ALD via gut-liver axis. However, gut non-bacterial communities including fungi, viruses, and archaea, which may also participate in the disease, has received little attention relative to the gut bacterial community. This paper will systematically collect the latest literatures reporting non-bacterial communities in mammalian health and disease, and review their mechanisms in promoting the development of ALD including CLEC7A pathway, Candidalysin (a peptide toxin secreted by Candida albicans), metabolites, and other chemical substances secreted or regulated by gut commensal mycobiome, virome, and archaeome, hoping to bring novel insights on our current knowledge of ALD.

Entities:  

Keywords:  Alcohol-associated liver disease; CLEC7A; archaeome; gut barrier; gut-liver axis; immune response; liver sinusoid endothelial cells; mycobiome; virome

Mesh:

Substances:

Year:  2021        PMID: 34711112      PMCID: PMC8565833          DOI: 10.1080/19490976.2021.1984122

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  173 in total

Review 1.  Adaptations to energy stress dictate the ecology and evolution of the Archaea.

Authors:  David L Valentine
Journal:  Nat Rev Microbiol       Date:  2007-03-05       Impact factor: 60.633

Review 2.  Bacteriophages of the Human Gut: The "Known Unknown" of the Microbiome.

Authors:  Andrey N Shkoporov; Colin Hill
Journal:  Cell Host Microbe       Date:  2019-02-13       Impact factor: 21.023

3.  Saccharomyces cerevisiae fungemia, a possible consequence of the treatment of Clostridium difficile colitis with a probioticum.

Authors:  I Santino; A Alari; S Bono; E Teti; M Marangi; A Bernardini; L Magrini; S Di Somma; A Teggi
Journal:  Int J Immunopathol Pharmacol       Date:  2014 Jan-Mar       Impact factor: 3.219

4.  Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury.

Authors:  Karim C El Kasmi; Aimee L Anderson; Michael W Devereaux; Sophie A Fillon; J Kirk Harris; Mark A Lovell; Milton J Finegold; Ronald J Sokol
Journal:  Hepatology       Date:  2012-03-18       Impact factor: 17.425

5.  Role of endotoxin in the hypermetabolic state after acute ethanol exposure.

Authors:  C A Rivera; B U Bradford; V Seabra; R G Thurman
Journal:  Am J Physiol       Date:  1998-12

Review 6.  Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?

Authors:  Naga S Betrapally; Patrick M Gillevet; Jasmohan S Bajaj
Journal:  Gastroenterology       Date:  2016-03-04       Impact factor: 22.682

Review 7.  Liver sinusoidal endothelial cells: Physiology and role in liver diseases.

Authors:  Johanne Poisson; Sara Lemoinne; Chantal Boulanger; François Durand; Richard Moreau; Dominique Valla; Pierre-Emmanuel Rautou
Journal:  J Hepatol       Date:  2016-07-14       Impact factor: 25.083

Review 8.  The discussion goes on: What is the role of Euryarchaeota in humans?

Authors:  H-P Horz; G Conrads
Journal:  Archaea       Date:  2010-12-30       Impact factor: 3.273

Review 9.  Close Encounters of Three Kinds: Bacteriophages, Commensal Bacteria, and Host Immunity.

Authors:  Eric C Keen; Gautam Dantas
Journal:  Trends Microbiol       Date:  2018-06-13       Impact factor: 17.079

Review 10.  Regulation of Intestinal Barrier Function by Microbial Metabolites.

Authors:  Sweta Ghosh; Caleb Samuel Whitley; Bodduluri Haribabu; Venkatakrishna Rao Jala
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2021-02-18
View more
  2 in total

1.  Intestinal Barrier Dysfunction in Fatty Liver Disease: Roles of Microbiota, Mucosal Immune System, and Bile Acids.

Authors:  Biki Gupta; Ravi Rai; Michael Oertel; Reben Raeman
Journal:  Semin Liver Dis       Date:  2022-06-23       Impact factor: 6.512

Review 2.  Trust Your Gut: The Association of Gut Microbiota and Liver Disease.

Authors:  Ridda Manzoor; Weshah Ahmed; Nariman Afify; Mashal Memon; Maryam Yasin; Hamda Memon; Mohammad Rustom; Mohannad Al Akeel; Noora Alhajri
Journal:  Microorganisms       Date:  2022-05-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.